Spots Global Cancer Trial Database for cord blood transplant
Every month we try and update this database with for cord blood transplant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia | NCT04103879 | High Risk Hemat... Cord Blood Tran... | ECT-001-CB (UM1... | 18 Years - 70 Years | ExCellThera inc. | |
| Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention | NCT02423915 | Leukemia Lymphoma | Rituximab Fludarabine Cyclophosphamid... Total Body Radi... Fucosylated Reg... Cord Blood Infu... Mycophenolate m... Sirolimus Bone Marrow Asp... G-CSF Non-Fucosylated... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia | NCT03913026 | High Risk Hemat... Cord Blood Tran... | Transplant with... | 18 Years - 70 Years | Ciusss de L'Est de l'Île de Montréal | |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | NCT01471067 | Blood And Marro... Leukemia Lymphoma Transplantation... Transplantation... | Melphalan Fludarabine Mycophenolate m... Tacrolimus Cord Blood Infu... Rituximab ATG Busulfan Clofarabine Total Body Irra... | 1 Year - 80 Years | M.D. Anderson Cancer Center | |
| US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies | NCT04990323 | High Risk Myelo... Cord Blood Tran... | ECT-001-CB (UM1... | 0 Years - 21 Years | ExCellThera inc. | |
| Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention | NCT02423915 | Leukemia Lymphoma | Rituximab Fludarabine Cyclophosphamid... Total Body Radi... Fucosylated Reg... Cord Blood Infu... Mycophenolate m... Sirolimus Bone Marrow Asp... G-CSF Non-Fucosylated... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Autologous and Allogeneic Transplant for Relapsed Lymphoma | NCT00802113 | Non-Hodgkin's L... Hodgkins Diseas... | Fludarabine Busulfan Anti-Thymocyte ... | - 55 Years | Columbia University | |
| UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia | NCT03913026 | High Risk Hemat... Cord Blood Tran... | Transplant with... | 18 Years - 70 Years | Ciusss de L'Est de l'Île de Montréal | |
| Cord Blood Transplant in Adults With Blood Cancers | NCT05884333 | Acute Myelogeno... Acute Lymphobla... Chronic Myeloge... Myelodysplastic... Myeloproliferat... Non-Hodgkin's L... | Conditioning Ch... Cord blood graf... | 21 Years - 65 Years | Memorial Sloan Kettering Cancer Center | |
| Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation | NCT01554254 | Cord Blood Tran... Hematologic Mal... Inherited Metab... | TXA127 | 6 Months - 20 Years | Tarix Pharmaceuticals | |
| Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma | NCT00670410 | Neuroblastoma | Related donor t... Cord blood tran... Busulfan Thymoglobulin Fludarabine | - 30 Years | Columbia University | |
| Autologous and Allogeneic Transplant for Relapsed Lymphoma | NCT00802113 | Non-Hodgkin's L... Hodgkins Diseas... | Fludarabine Busulfan Anti-Thymocyte ... | - 55 Years | Columbia University | |
| Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation | NCT00328237 | Acute Myeloid L... Acute Lymphobla... Chronic Myeloid... Non-Hodgkin Lym... Myelodysplastic... | Cord Blood Tran... | 18 Years - 49 Years | Colorado Blood Cancer Institute | |
| Cord Blood Transplant in Adults With Blood Cancers | NCT05884333 | Acute Myelogeno... Acute Lymphobla... Chronic Myeloge... Myelodysplastic... Myeloproliferat... Non-Hodgkin's L... | Conditioning Ch... Cord blood graf... | 21 Years - 65 Years | Memorial Sloan Kettering Cancer Center | |
| Double Cord Versus Haploidentical (BMT CTN 1101) | NCT01597778 | Acute Lymphocyt... Acute Myelogeno... Burkitt's Lymph... Follicular Lymp... Hodgkin Lymphom... Mantle Cell Lym... Non-Hodgkin Lym... | Haploidentical ... Double Umbilica... | 18 Years - 70 Years | Medical College of Wisconsin | |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | NCT01471067 | Blood And Marro... Leukemia Lymphoma Transplantation... Transplantation... | Melphalan Fludarabine Mycophenolate m... Tacrolimus Cord Blood Infu... Rituximab ATG Busulfan Clofarabine Total Body Irra... | 1 Year - 80 Years | M.D. Anderson Cancer Center | |
| Cord Blood Transplantation in Patients With Advanced Lymphoid Malignancies | NCT01966510 | Patients With A... | Cord Blood Tran... | 18 Years - 65 Years | Assistance Publique - Hôpitaux de Paris |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
